Cargando…
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
Nitrogen mustard is a chemotherapeutic agent that has a well-documented safety and efficacy profile in the treatment of cutaneous T-cell lymphoma. Development of nitrogen mustard formulations and treatment regimens has been studied extensively over the last 40 years. In the last 5 years, a new gel f...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798535/ https://www.ncbi.nlm.nih.gov/pubmed/29440874 http://dx.doi.org/10.2147/DDDT.S137106 |
_version_ | 1783297857635221504 |
---|---|
author | Liner, Kendall Brown, Celeste McGirt, Laura Y |
author_facet | Liner, Kendall Brown, Celeste McGirt, Laura Y |
author_sort | Liner, Kendall |
collection | PubMed |
description | Nitrogen mustard is a chemotherapeutic agent that has a well-documented safety and efficacy profile in the treatment of cutaneous T-cell lymphoma. Development of nitrogen mustard formulations and treatment regimens has been studied extensively over the last 40 years. In the last 5 years, a new gel formulation has been developed that is associated with a decrease in delayed hypersensitivity reactions. The authors in this review found that while the gel formulation may result in a decrease of allergic contact dermatitis, this advantage has been replaced by a higher number of irritant contact reactions and a decrease in complete response rate. The gel formulation has a complete response rate of 13.8%, which is a decrease in efficacy when compared to aqueous-based preparations of similar concentrations. |
format | Online Article Text |
id | pubmed-5798535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57985352018-02-13 Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data Liner, Kendall Brown, Celeste McGirt, Laura Y Drug Des Devel Ther Review Nitrogen mustard is a chemotherapeutic agent that has a well-documented safety and efficacy profile in the treatment of cutaneous T-cell lymphoma. Development of nitrogen mustard formulations and treatment regimens has been studied extensively over the last 40 years. In the last 5 years, a new gel formulation has been developed that is associated with a decrease in delayed hypersensitivity reactions. The authors in this review found that while the gel formulation may result in a decrease of allergic contact dermatitis, this advantage has been replaced by a higher number of irritant contact reactions and a decrease in complete response rate. The gel formulation has a complete response rate of 13.8%, which is a decrease in efficacy when compared to aqueous-based preparations of similar concentrations. Dove Medical Press 2018-01-31 /pmc/articles/PMC5798535/ /pubmed/29440874 http://dx.doi.org/10.2147/DDDT.S137106 Text en © 2018 Liner et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Liner, Kendall Brown, Celeste McGirt, Laura Y Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data |
title | Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data |
title_full | Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data |
title_fullStr | Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data |
title_full_unstemmed | Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data |
title_short | Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data |
title_sort | clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous t-cell lymphoma: a review on current efficacy and safety data |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798535/ https://www.ncbi.nlm.nih.gov/pubmed/29440874 http://dx.doi.org/10.2147/DDDT.S137106 |
work_keys_str_mv | AT linerkendall clinicalpotentialofmechlorethaminegelforthetopicaltreatmentofmycosisfungoidestypecutaneoustcelllymphomaareviewoncurrentefficacyandsafetydata AT brownceleste clinicalpotentialofmechlorethaminegelforthetopicaltreatmentofmycosisfungoidestypecutaneoustcelllymphomaareviewoncurrentefficacyandsafetydata AT mcgirtlauray clinicalpotentialofmechlorethaminegelforthetopicaltreatmentofmycosisfungoidestypecutaneoustcelllymphomaareviewoncurrentefficacyandsafetydata |